ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks”

May 13, 1988

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Blackburn Wins BMS Award

May 23, 2003